TSX · BLCO.TO
Bausch + Lomb Corporation
CA$28.75+CA$0.19 (+0.67%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 3.3% below the high.
Loading market information…
OTC · LUFFF · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Herbal Dispatch Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.17% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Herbal Dispatch Inc.’s next earnings report is currently expected on Nov 20, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Herbal Dispatch Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Herbal Dispatch Inc., together with its subsidiaries, engages in the sale of cannabis and cannabis related products in Canada and internationally. The company offers dried flowers, pre-rolls, concentrates, vapes, edibles, oils and capsules, topicals, CBD, seeds, and accessories, as well as small-batch craft and curated cannabis products. It also provides packaging and processing services. The company sells its products under various brand names through cannabis e-commerce platforms. It exports its products. The company was founded in 2015 and is headquartered in Vancouver, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:03 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$28.75+CA$0.19 (+0.67%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 3.3% below the high.
$0.73$0.00 (0.0%)
Noveris Health Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 64.22% below the high.
$0.02-$0.00 (-5.56%)
Rhelion Life Sciences Corp.’s quoted price sits in the lower half of its reported 52-week range, 60.47% below the high.
£0.01£0.00 (0.0%)
CelLBxHealth plc’s quoted price sits in the lower half of its reported 52-week range, 77.68% below the high.
$0.25$0.00 (0.0%)
BioQuest Corp.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.
$0.02-$0.00 (-20.0%)
Numinus Wellness Inc.’s quoted price sits in the lower half of its reported 52-week range, 70.91% below the high.
SEK 7.61+SEK 0.01 (+0.13%)
Vivesto AB’s quoted price sits in the lower half of its reported 52-week range, 72.12% below the high.
$0.01$0.00 (0.0%)
Sirona Biochem Corp.’s quoted price sits in the lower half of its reported 52-week range, 57.85% below the high.
